The DOI matches its OpenAlex record.
The challenges of emerging infectious diseases. Development and spread of multiply-resistant bacterial pathogens
Abstract
Resistance is an emerging problem in human medicine and the effects of resistance are being noted on an ever-increasing scale. Whether it is treatment of nosocomial bacteremia in New York City or community-acquired dysentery in Central Africa, multiresistant organisms are diminishing our ability to control the spread of infectious diseases. Clearly, the rate at which resistant organisms develop is not solely a function of the use of antimicrobials in humans, but is also highly influenced by the use of these agents in veterinary medicine, animal husbandry, agriculture, and aquaculture, as has been emphasized at recent meetings sponsored by organizations such as Rockefeller University and the American Society for Microbiology, and in the report on bacterial resistance recently issued by the US Office of Technology Assessment. We have entered an era where both physicians and patients must take on the responsibility to use antimicrobials wisely and judiciously. Just as in the days at the turn of the century when the public was an integral part of establishing quarantines for infectious diseases, now again the public's cooperation must be sought for this latest threat to public health. The multiresistant organisms of the 1990s are a grim warning of the possibility of the postantibiotic era.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Green Synthesis of Metallic Nanoparticles: Applications and Limitations
Dikshit, P., Kumar, J., Das, A., Sadhu, S., Sharma, S., Singh, S., Gupta, P., & Kim, B. (2021) · Catalysts · doi:10.3390/catal11080902 · Cited by 882
Fagon, J.-Y., Chastre, J., Wolff, M., Gervais, C., Parer-Aubas, S., Stéphan, F., Similowski, T., Mercat, A., Diehl, J.-L., Sollet, J.-P., et al. (2000) · Annals of Internal Medicine · doi:10.7326/0003-4819-132-8-200004180-00004 · Cited by 854
Antimicrobial Stewardship Programs in Health Care Systems
MacDougall, C., & Polk, R. E. (2005) · Clinical Microbiology Reviews · doi:10.1128/cmr.18.4.638-656.2005 · Cited by 705
Reducing Antibiotic Use in Children: A Randomized Trial in 12 Practices
Finkelstein, J. A., Davis, R. L., Dowell, S. F., Metlay, J. P., Soumerai, S. B., Rifas-Shiman, S. L., Higham, M., Miller, Z., Miroshnik, I., Pedan, A., et al. (2001) · Pediatrics · doi:10.1542/peds.108.1.1 · Cited by 674
Probiotics for preventing acute upper respiratory tract infections
Hao, Q., Dong, B. R., & Wu, T. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006895.pub3 · Cited by 569
Metadata
- Authors
- Tenover, F. C.
- Venue
- JAMA
- Publisher
- American Medical Association
- Published
- 1996-01-24
- Volume
- 275
- Issue
- 4
- Pages
- 300-304
- ISSN
- 0002-9955 (ISSN-L)
- OpenAlex
- W4247971812
- Cited by
- 253
- References
- 0
- FWCI
- 16.19
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The challenges of emerging infectious diseases. Development and spread of multiply-resistant bacterial pathogens. https://app.cochat.ai/papers/10.1001/jama.275.4.300
- The paper
- Tenover, F. C. (1996). The challenges of emerging infectious diseases. Development and spread of multiply-resistant bacterial pathogens. JAMA. https://doi.org/10.1001/jama.275.4.300
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.